Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
 
Authors :  I. Petitpas, C. E. Petersen, C. E. Ha, A. A. Bhattacharya, P. A. Zunszain, J. Ghuman, N. V. Bhagavan, S. Curry
Date :  05 Mar 03  (Deposition) - 16 May 03  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.80
Chains :  Asym./Biol. Unit :  A
Keywords :  Plasma Protein, Hormone-Binding, Lipid-Binding, Thyroxine, Familial Dysalbuminemic Hyperthyroxinemia (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  I. Petitpas, C. E. Petersen, C. E. Ha, A. A. Bhattacharya, P. A. Zunszain, J. Ghuman, N. V. Bhagavan, S. Curry
Structural Basis Of Albumin-Thyroxine Interactions And Familial Dysalbuminemic Hyperthyroxinemia
Proc. Natl. Acad. Sci. Usa V. 100 6440 2003
PubMed-ID: 12743361  |  Reference-DOI: 10.1073/PNAS.1137188100

(-) Compounds

Molecule 1 - SERUM ALBUMIN
    ChainsA
    EngineeredYES
    Expression SystemPICHIA PASTORIS
    Expression System Taxid4922
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 4)

Asymmetric/Biological Unit (1, 4)
No.NameCountTypeFull Name
1T444Ligand/Ion3,5,3',5'-TETRAIODO-L-THYRONINE

(-) Sites  (4, 4)

Asymmetric Unit (4, 4)
No.NameEvidenceResiduesDescription
1AC1SOFTWARETYR A:150 , LYS A:195 , LYS A:199 , TRP A:214 , PRO A:218 , LEU A:219 , ARG A:222 , LEU A:238 , ARG A:257 , ILE A:290BINDING SITE FOR RESIDUE T44 A3001
2AC2SOFTWARELEU A:387 , GLN A:390 , ASN A:391 , ALA A:406 , LEU A:407 , ARG A:410 , TYR A:411 , SER A:489BINDING SITE FOR RESIDUE T44 A3002
3AC3SOFTWAREALA A:300 , THR A:506 , PHE A:507 , THR A:508 , LYS A:524 , PHE A:551BINDING SITE FOR RESIDUE T44 A3003
4AC4SOFTWAREPHE A:507 , ALA A:528 , LEU A:532 , VAL A:547 , LEU A:575BINDING SITE FOR RESIDUE T44 A3004

(-) SS Bonds  (17, 17)

Asymmetric/Biological Unit
No.Residues
1A:53 -A:62
2A:75 -A:91
3A:90 -A:101
4A:124 -A:169
5A:168 -A:177
6A:200 -A:246
7A:245 -A:253
8A:265 -A:279
9A:278 -A:289
10A:316 -A:361
11A:360 -A:369
12A:392 -A:438
13A:437 -A:448
14A:461 -A:477
15A:476 -A:487
16A:514 -A:559
17A:558 -A:567

(-) Cis Peptide Bonds  (1, 1)

Asymmetric/Biological Unit
No.Residues
1Glu A:95 -Pro A:96

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (55, 55)

Asymmetric/Biological Unit (55, 55)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_010657F73YALBU_HUMANPolymorphism  ---AF49Y
02UniProtVAR_000507E84KALBU_HUMANPolymorphism77050410AE60K
03UniProtVAR_000508D87NALBU_HUMANPolymorphism78574148AD63N
04UniProtVAR_013011L90PALBU_HUMANDisease (FDAH)77892378AL66P
05UniProtVAR_014290E121GALBU_HUMANPolymorphism  ---AE97G
06UniProtVAR_000510R138GALBU_HUMANPolymorphism77238412AR114G
07UniProtVAR_000511E143KALBU_HUMANPolymorphism75522063AE119K
08UniProtVAR_013012V146EALBU_HUMANPolymorphism77752336AV122E
09UniProtVAR_000512H152RALBU_HUMANPolymorphism80095457AH128R
10UniProtVAR_000513C201FALBU_HUMANPolymorphism77656691AC177F
11UniProtVAR_014291A215TALBU_HUMANPolymorphism3210154AA191T
12UniProtVAR_014292A215VALBU_HUMANPolymorphism3204504AA191V
13UniProtVAR_014293Q220LALBU_HUMANPolymorphism3210163AQ196L
14UniProtVAR_000514R242HALBU_HUMANDisease (FDAH)75002628AP218H
15UniProtVAR_013013R242PALBU_HUMANDisease (FDAH)75002628AP218P
16UniProtVAR_000515K249QALBU_HUMANPolymorphism79804069AK225Q
17UniProtVAR_000516K264EALBU_HUMANPolymorphism79377490AK240E
18UniProtVAR_000517Q292RALBU_HUMANPolymorphism80002911AQ268R
19UniProtVAR_000518D293GALBU_HUMANPolymorphism79744198AD269G
20UniProtVAR_000519K300NALBU_HUMANPolymorphism74718349AK276N
21UniProtVAR_000520K337NALBU_HUMANPolymorphism72552710AK313N
22UniProtVAR_013014D338GALBU_HUMANPolymorphism76242087AD314G
23UniProtVAR_013015D338VALBU_HUMANPolymorphism76242087AD314V
24UniProtVAR_000521N342KALBU_HUMANPolymorphism77544362AN318K
25UniProtVAR_000522A344TALBU_HUMANPolymorphism78953271AA320T
26UniProtVAR_000523E345KALBU_HUMANPolymorphism72552711AE321K
27UniProtVAR_000524E357KALBU_HUMANPolymorphism77354753AE333K
28UniProtVAR_000525E378KALBU_HUMANPolymorphism76593094AE354K
29UniProtVAR_000526E382KALBU_HUMANPolymorphism75791663AE358K
30UniProtVAR_013016K383NALBU_HUMANPolymorphism75069738AK359N
31UniProtVAR_000527D389HALBU_HUMANPolymorphism77187142AD365H
32UniProtVAR_000528D389VALBU_HUMANPolymorphism78538497AD365V
33UniProtVAR_000529K396EALBU_HUMANPolymorphism78166690AK372E
34UniProtVAR_000530D399NALBU_HUMANPolymorphism77514449AD375N
35UniProtVAR_000531E400KALBU_HUMANPolymorphism79047363AE376K
36UniProtVAR_000532E400QALBU_HUMANPolymorphism79047363AE376Q
37UniProtVAR_000533E406KALBU_HUMANPolymorphism76483862AE382K
38UniProtVAR_014294E420KALBU_HUMANPolymorphism  ---AE396K
39UniProtVAR_013017R434CALBU_HUMANPolymorphism78575701AR410C
40UniProtVAR_014295K490EALBU_HUMANPolymorphism1063469AK466E
41UniProtVAR_000534E503KALBU_HUMANPolymorphism80259813AE479K
42UniProtVAR_000535D518NALBU_HUMANPolymorphism75920790AD494N
43UniProtVAR_000536E525KALBU_HUMANPolymorphism75523493AE501K
44UniProtVAR_000537E529KALBU_HUMANPolymorphism74826639AE505K
45UniProtVAR_013018V557MALBU_HUMANPolymorphism78284052AV533M
46UniProtVAR_000538K560EALBU_HUMANPolymorphism77645174AK536E
47UniProtVAR_000539K565EALBU_HUMANPolymorphism80345158AK541E
48UniProtVAR_000541D574AALBU_HUMANPolymorphism79738788AD550A
49UniProtVAR_000540D574GALBU_HUMANPolymorphism79738788AD550G
50UniProtVAR_013019K584EALBU_HUMANPolymorphism76671808AK560E
51UniProtVAR_000542D587NALBU_HUMANPolymorphism76587671AD563N
52UniProtVAR_000543E589KALBU_HUMANPolymorphism75709682AE565K
53UniProtVAR_000544E594KALBU_HUMANPolymorphism79228041AE570K
54UniProtVAR_000545K597EALBU_HUMANPolymorphism80106970AK573E
55UniProtVAR_000546K598NALBU_HUMANPolymorphism75738598AK574N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 5)

Asymmetric/Biological Unit (2, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ALBUMIN_2PS51438 Albumin domain profile.ALBU_HUMAN19-210
211-403
404-601
  2-
A:187-379
A:380-575
2ALBUMIN_1PS00212 Albumin domain signature.ALBU_HUMAN185-209
377-401
575-599
  3A:161-185
A:353-377
A:551-575

(-) Exons   (13, 13)

Asymmetric/Biological Unit (13, 13)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.2aENST000002958972aENSE00002075693chr4:74269956-74270123168ALBU_HUMAN1-27270--
1.3aENST000002958973aENSE00001076782chr4:74270833-7427089058ALBU_HUMAN27-46201A:5-2218
1.4bENST000002958974bENSE00001076799chr4:74272346-74272478133ALBU_HUMAN46-90451A:22-6645
1.5aENST000002958975aENSE00001076811chr4:74274311-74274522212ALBU_HUMAN91-161711A:67-137 (gaps)71
1.7dENST000002958977dENSE00001076808chr4:74275072-74275204133ALBU_HUMAN161-205451A:137-18145
1.8aENST000002958978aENSE00001076797chr4:74276029-7427612698ALBU_HUMAN206-238331A:182-21433
1.9aENST000002958979aENSE00001076788chr4:74277713-74277842130ALBU_HUMAN238-281441A:214-25744
1.10bENST0000029589710bENSE00001076792chr4:74279137-74279351215ALBU_HUMAN282-353721A:258-32972
1.11aENST0000029589711aENSE00001076805chr4:74280752-74280884133ALBU_HUMAN353-397451A:329-37345
1.12ENST0000029589712ENSE00001076781chr4:74281973-7428207098ALBU_HUMAN398-430331A:374-40633
1.13bENST0000029589713bENSE00001076796chr4:74283248-74283386139ALBU_HUMAN430-476471A:406-45247
1.14bENST0000029589714bENSE00001076790chr4:74283805-74284028224ALBU_HUMAN477-551751A:453-52775
1.16bENST0000029589716bENSE00001076802chr4:74285224-74285356133ALBU_HUMAN551-595451A:527-57145
1.18aENST0000029589718aENSE00001076795chr4:74285971-7428603868ALBU_HUMAN596-609141A:572-5754
1.20jENST0000029589720jENSE00001823230chr4:74286809-74287129321ALBU_HUMAN-00--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:559
 aligned with ALBU_HUMAN | P02768 from UniProtKB/Swiss-Prot  Length:609

    Alignment length:571
                                    38        48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438       448       458       468       478       488       498       508       518       528       538       548       558       568       578       588       598 
           ALBU_HUMAN    29 SEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKL 599
               SCOP domains d1hk3a1 A:5-196 Serum albumin                                                                                                                                                                   d1hk3a2 A:197-388 Serum albumin                                                                                                                                                                 d1hk3a3 A:389-575 Serum albumin                                                                                                                                                             SCOP domains
               CATH domains 1hk3A01 A:5-107  [code=1.10.246.10, no name defined]                                                   1hk3A02 A:108-197  [code=1.10.246.10, no name defined]                                    -------1hk3A03 A:205-296  [code=1.10.246.10, no name defined]                                      1hk3A04 A:297-382  [code=1.10.246.10, no name defined]                                1hk3A05 A:383-494  [code=1.10.246.10, no name defined]                                                          1hk3A06 A:495-572  [code=1.10.246.10, no name defined]                        --- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhh........hhhhhhhhhhhh------------.........hhhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh.......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhh.hhhhhhhhhhhh..........hhhhhhh...hhhhhhhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhh...hhhhhhhhh............hhhhh.hhhhhh.hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) --------------------------------------------Y----------K--N--P------------------------------G----------------G----K--E-----R------------------------------------------------F-------------T----L---------------------H------Q--------------E---------------------------RG------N------------------------------------NG---K-TK-----------K--------------------K---KN-----H------E--NK-----K-------------K-------------C-------------------------------------------------------E------------K--------------N------K---K---------------------------M--E----E--------A---------E--N-K----K--EN- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------V--------------------------P-----------------------------------------------------------------------------------------------V--------------------------------------------------V----------Q-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G------------------------- SAPs(SNPs) (2)
                PROSITE (1) ALBUMIN_2  PDB: - UniProt: 19-210                                                                                                                                                     ALBUMIN_2  PDB: A:187-379 UniProt: 211-403                                                                                                                                                       ALBUMIN_2  PDB: A:380-575 UniProt: 404-601                                                                                                                                                           PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:161-185-----------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:353-377-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:551-575 PROSITE (2)
           Transcript 1 (1) Exon 1.3a         --------------------------------------------Exon 1.5a  PDB: A:67-137 (gaps) UniProt: 91-161                        --------------------------------------------Exon 1.8a  PDB: A:182-214        -------------------------------------------Exon 1.10b  PDB: A:258-329 UniProt: 282-353                             --------------------------------------------Exon 1.12  PDB: A:374-406        ----------------------------------------------Exon 1.14b  PDB: A:453-527 UniProt: 477-551                                --------------------------------------------1.18 Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.4b  PDB: A:22-66 UniProt: 46-90       ----------------------------------------------------------------------Exon 1.7d  PDB: A:137-181 UniProt: 161-205   --------------------------------Exon 1.9a  PDB: A:214-257 UniProt: 238-281  -----------------------------------------------------------------------Exon 1.11a  PDB: A:329-373 UniProt: 353-397  --------------------------------Exon 1.13b  PDB: A:406-452 UniProt: 430-476    --------------------------------------------------------------------------Exon 1.16b  PDB: A:527-571 UniProt: 551-595  ---- Transcript 1 (2)
                 1hk3 A   5 SEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCT------------DCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVAPLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKL 575
                                    14        24        34        44        54        64        74 |       -    |   94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464       474       484       494       504       514       524       534       544       554       564       574 
                                                                                                  76           89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 3)

Asymmetric/Biological Unit

(-) CATH Domains  (1, 6)

Asymmetric/Biological Unit

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1HK3)

(-) Gene Ontology  (45, 45)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (ALBU_HUMAN | P02768)
molecular function
    GO:0003677    DNA binding    Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
    GO:0016209    antioxidant activity    Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
    GO:0051087    chaperone binding    Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
    GO:0005507    copper ion binding    Interacting selectively and non-covalently with copper (Cu) ions.
    GO:0008144    drug binding    Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0005504    fatty acid binding    Interacting selectively and non-covalently with fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0008289    lipid binding    Interacting selectively and non-covalently with a lipid.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0019825    oxygen binding    Interacting selectively and non-covalently with oxygen (O2).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0030170    pyridoxal phosphate binding    Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
    GO:0015643    toxic substance binding    Interacting selectively and non-covalently with a toxic substance, a poisonous substance that causes damage to biological systems.
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0015721    bile acid and bile salt transport    The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0098869    cellular oxidant detoxification    Any process carried out at the cellular level that reduces or removes the toxicity superoxide radicals or hydrogen peroxide.
    GO:0009267    cellular response to starvation    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
    GO:0019836    hemolysis by symbiont of host erythrocytes    The cytolytic destruction of red blood cells, with the release of intracellular hemoglobin, in the host organism by a symbiont. The host is defined as the larger of the organisms involved in a symbiotic interaction.
    GO:0042157    lipoprotein metabolic process    The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
    GO:0051659    maintenance of mitochondrion location    Any process in which a mitochondrion is maintained in a specific location within a cell and prevented from moving elsewhere.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0043069    negative regulation of programmed cell death    Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0046010    positive regulation of circadian sleep/wake cycle, non-REM sleep    Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep.
    GO:0006898    receptor-mediated endocytosis    An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
    GO:0046689    response to mercury ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
    GO:0007584    response to nutrient    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
    GO:0010033    response to organic substance    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
    GO:0070541    response to platinum ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platinum stimulus.
    GO:0001895    retina homeostasis    A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
    GO:0043252    sodium-independent organic anion transport    The directed, sodium-independent, movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0006810    transport    The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0005604    basement membrane    A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0043209    myelin sheath    An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.
    GO:0043234    protein complex    A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    T44  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Glu A:95 - Pro A:96   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1hk3
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ALBU_HUMAN | P02768
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  615999
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ALBU_HUMAN | P02768
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ALBU_HUMAN | P027681ao6 1bj5 1bke 1bm0 1e78 1e7a 1e7b 1e7c 1e7e 1e7f 1e7g 1e7h 1e7i 1gni 1gnj 1h9z 1ha2 1hk1 1hk2 1hk4 1hk5 1n5u 1o9x 1tf0 1uor 1ysx 2bx8 2bxa 2bxb 2bxc 2bxd 2bxe 2bxf 2bxg 2bxh 2bxi 2bxk 2bxl 2bxm 2bxn 2bxo 2bxp 2bxq 2esg 2i2z 2i30 2n0x 2vdb 2vue 2vuf 2xsi 2xvq 2xvu 2xvv 2xvw 2xw0 2xw1 2ydf 3a73 3b9l 3b9m 3cx9 3jqz 3jry 3lu6 3lu7 3lu8 3sqj 3tdl 3uiv 4bke 4e99 4emx 4g03 4g04 4hgk 4hgm 4iw1 4iw2 4k2c 4k71 4l8u 4l9k 4l9q 4la0 4lb2 4lb9 4n0f 4n0u 4s1y 4z69 5fuo 5id7 5ifo 5ijf 5ujb 5x52

(-) Related Entries Specified in the PDB File

1ao6 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1bj5 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1bke HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID
1bm0 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e78 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e7a CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
1e7b CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE
1e7c HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
1e7e HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID
1e7f HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID
1e7g HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1e7h HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID
1e7i HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID
1gni HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC ACID)
1gnj HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
1h9z HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
1ha2 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) ENANTIOMER OF WARFARIN
1hk1 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1hk2 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE
1hk4 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE AND MYRISTIC ACID
1hk5 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE AND MYRISTIC ACID
1o9x HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
1uor X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN